These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8222318)

  • 1. Why do patients develop reactions to streptokinase?
    Lynch M; Pentecost BL; Littler WA; Stockley RA
    Clin Exp Immunol; 1993 Nov; 94(2):279-85. PubMed ID: 8222318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of in vivo immune complex formation and complement activation in patients receiving intravenous streptokinase.
    Freysdottir J; Ormarsdottir S; Sigfusson A
    Clin Exp Immunol; 1993 Nov; 94(2):286-90. PubMed ID: 8222319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation reaches maximum during equilibrium between antigen and antibody in an in vitro model for thrombolysis with streptokinase.
    Leinøe E; Pachaï A; Brandslund I
    APMIS; 2000 Oct; 108(10):685-8. PubMed ID: 11200823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaphylactoid purpura like vasculitis following fibrinolytic therapy: role of the immune response to streptokinase.
    Lantin JP; Gattesco S; Duclos A; Zanchi A; Schaller MD; Pecoud A; Aubert V
    Clin Exp Rheumatol; 1994; 12(4):429-33. PubMed ID: 7955610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaphylactic reactivity to streptokinase.
    McGrath KG; Patterson R
    JAMA; 1984 Sep; 252(10):1314-7. PubMed ID: 6433051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anaphylactic reaction in streptokinase therapy].
    Hohage H; Schulte B; Pfeiff B; Pullmann H
    Wien Klin Wochenschr; 1993; 105(6):176-8. PubMed ID: 8475630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overt and subclinical reactions to streptokinase in acute myocardial infarction.
    Lynch M; Pentecost BL; Littler WA; Stockley RA
    Am J Cardiol; 1994 Nov; 74(9):849-52. PubMed ID: 7977112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity reactions to streptokinase in patients with high pre-treatment antistreptokinase antibody and neutralisation titres.
    Lee HS; Yule S; McKenzie A; Cross S; Reid T; Davidson R; Jennings K
    Eur Heart J; 1993 Dec; 14(12):1640-3. PubMed ID: 8131761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C3c and C3d fragments of human C3 bind myeloma IgG1 and IgG3 proteins.
    Hautanen A; Sarnesto A; Keski-Oja J; Seppälä I
    Immunol Lett; 1982 Nov; 5(5):227-32. PubMed ID: 6984423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of complement-mediated anaphylaxis in humans. The role of IgG subclasses (IgG1 and/or IgG4) in the complement-activating capacity of immune complexes.
    Bergamaschini L; Santangelo T; Faricciotti A; Ciavarella N; Mannucci PM; Agostoni A
    J Immunol; 1996 Feb; 156(3):1256-61. PubMed ID: 8558005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The distribution of antibodies to streptokinase.
    Lynch M; Pentecost BL; Littler WA; Stockley RA
    Postgrad Med J; 1996 May; 72(847):290-2. PubMed ID: 8761502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of C4d and C3d and their complex formation with serum albumin.
    Petersen NE; Teisner B; Folkersen J; Svehag SE
    Acta Pathol Microbiol Immunol Scand C; 1987 Aug; 95(4):129-35. PubMed ID: 3499750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunology of streptokinase in human subjects.
    McGrath K; Patterson R
    Clin Exp Immunol; 1985 Nov; 62(2):421-6. PubMed ID: 4085148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute complement activation during an anaphylactoid reaction to blood transfusion and the disappearance rate of C3c and C3d from the circulation.
    Teisner B; Brandslund I; Grunnet N; Hansen LK; Thellesen J; Svehag SE
    J Clin Lab Immunol; 1983 Oct; 12(2):63-7. PubMed ID: 6606048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaphylaxis to L-asparaginase during treatment for acute lymphoblastic leukemia in children--evidence of a complement-mediated mechanism.
    Fabry U; Körholz D; Jürgens H; Göbel U; Wahn V
    Pediatr Res; 1985 Apr; 19(4):400-8. PubMed ID: 3858789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms Involved in Hypersensitivity Reactions to Polysulfone Hemodialysis Membranes.
    Rodríguez-Sanz A; Sánchez-Villanueva R; Domínguez-Ortega J; Fiandor AM; Ruiz MP; Trocoli F; Díaz-Tejeiro R; Cadenillas C; González E; Martínez V; López-Trascasa M; Quirce S; Selgas R; Bellón T
    Artif Organs; 2017 Nov; 41(11):E285-E295. PubMed ID: 28722144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of human complement by totally human monoclonal antibodies.
    Dillman SL; Strelkauskas AJ; Su HR; Boackle RJ
    Mol Immunol; 1995 Sep; 32(13):957-64. PubMed ID: 7477001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of hepatic necrosis and complement system activation in fulminant viral hepatitis].
    Hou J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Feb; 15(1):49-54. PubMed ID: 8324837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the IgE-basophil system and mild complement activation in haemophilia B with anti-factor IX neutralizing antibodies and anaphylaxis.
    Cugno M; Mancuso ME; Tedeschi A; Santagostino E; Lorini M; Carbonelli V; Peyvandi F; Mannucci PM
    Haemophilia; 2017 Jul; 23(4):e348-e353. PubMed ID: 28594432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.